# Study Using Plasma for Patients Requiring Emergency Surgery

> **NCT01221389** · PHASE4 · WITHDRAWN · sponsor: **Ottawa Hospital Research Institute**

## Conditions studied

- Hemorrhagic Shock
- Blood Coagulation Disorders
- Blood Products
- Trauma
- Ruptured AAA

## Interventions

- **DRUG:** Human Plasma

## Key facts

- **NCT ID:** NCT01221389
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-03
- **Primary completion:** 2012-12
- **Final completion:** 2013-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding to afford plasma
- **Last updated:** 2023-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01221389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01221389, "Study Using Plasma for Patients Requiring Emergency Surgery". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01221389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
